Royalty Pharma plcRPRXNASDAQ
LOADING
|||
Revenue Performance
Modest growth trend.
Left:
||||
Total revenue from sales of goods and services
Latest
$2.26B
↑ 13% above average
Average (9y)
$2.00B
Historical baseline
Range
High:$2.35B
Low:$1.60B
CAGR
+3.6%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $2.26B | -3.9% |
| 2023 | $2.35B | +5.2% |
| 2022 | $2.24B | -2.3% |
| 2021 | $2.29B | +7.9% |
| 2020 | $2.12B | +17.0% |
| 2019 | $1.81B | +1.1% |
| 2018 | $1.79B | +12.3% |
| 2017 | $1.60B | -14.9% |
| 2016 | $1.88B | +13.6% |
| 2015 | $1.65B | - |